deltatrials
Completed PHASE2 INTERVENTIONAL 3-arm NCT00322023

Safety and Effectiveness of D-serine in Schizophrenia

PK/PD Study of Escalating Dose D-serine as Adjunctive Treatment in Schizophrenia

Sponsor: Nathan Kline Institute for Psychiatric Research

Conditions Schizophrenia
Interventions D-serine
Updated 8 times since 2017 Last updated: Sep 11, 2020 Started: Mar 31, 2006 Primary completion: Jan 31, 2009 Completion: Jan 31, 2009
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Schizophrenia and is currently completed. Nathan Kline Institute for Psychiatric Research leads this study, which shows 8 recorded versions since 2006 — indicating limited longitudinal coverage. This study adds to the longitudinal dataset for psychiatric treatment development.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotUnknown Status~Feb 2017 – ~Jun 2018 · 16 months · monthly snapshotUnknown Status~Jun 2018 – ~Nov 2020 · 29 months · monthly snapshotUnknown Status~Nov 2020 – ~Jan 2021 · 2 months · monthly snapshotCompleted~Jan 2021 – ~Dec 2021 · 11 months · monthly snapshotCompleted~Dec 2021 – ~Jul 2024 · 31 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 22 months · monthly snapshotCompleted

Change History

8 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Dec 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jan 2021 — Dec 2021 [monthly]

    Completed PHASE2

  5. Nov 2020 — Jan 2021 [monthly]

    Completed PHASE2

    Status: Unknown Status → Completed

▶ Show 3 earlier versions

  1. Jun 2018 — Nov 2020 [monthly]

    Unknown Status PHASE2

  2. Feb 2017 — Jun 2018 [monthly]

    Unknown Status PHASE2

  3. Jan 2017 — Feb 2017 [monthly]

    Unknown Status PHASE2

    First recorded

Mar 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Nathan Kline Institute for Psychiatric Research
  • National Institute of Mental Health (NIMH)
Data source: Nathan Kline Institute for Psychiatric Research

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations